← Browse by Condition
Medical Condition

cardiac arrhythmia

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for cardiac arrhythmia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiac arrhythmia Clinical Trials

How many clinical trials are currently recruiting for cardiac arrhythmia?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for cardiac arrhythmia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiac arrhythmia?
cardiac arrhythmia research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiac arrhythmia clinical trial?
Eligibility criteria for cardiac arrhythmia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Mayo Clinic 1 trial
University Health Network, Toronto 1 trial
Giulio Zucchelli 1 trial

Recruiting Clinical Trials

NCT03049254
Recruiting
Mayo AVC Registry and Biobank
Enrollment
1,000 pts
Location
United States, Unite...
Sponsor
Mayo Clinic
View Trial →
NCT04843683
Recruiting
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias
Enrollment
60 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT05617456
Recruiting
Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice
Enrollment
4,100 pts
Location
Italy
Sponsor
Giulio Zucchelli
View Trial →

Related Conditions

arrhythmogenic right ventricular cardiomyopathy (1) cardiomyopathies (1) heart diseases (1) cardiovascular diseases (1) sudden cardiac arrest (1) sudden cardiac death (1) arrhythmogenic right ventricular dysplasia (1) arrhythmogenic ventricular cardiomyopathy (1) familial dilated cardiomyopathy (1) cardiovascular abnormalities (1) sarcoidosis (1) cardiac sarcoidosis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology